Art

J-GLOBAL ID：201902236299505797   Reference number：19A1712452

Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis

皮膚筋炎のサブセットにおける筋形質粘液ウイルス抵抗性蛋白質A発現の診断可能性【JST・京大機械翻訳】

Author (23)： Uruha A. (Mixed Research Unit (UMR) 974, Center of Research in Myology, Institute of Myology, Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Allenbach Y. (UMR974, Department of Internal Medicine and Clinical Immunology, Public Assistance-Hospitals of Paris (APHP), Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Allenbach Y. (Inflammation-Immunopathology-Biotherapy Department (DHU I2B), and Reference Center for Neuromuscular Pathologies, Institute of Myology, Paris, France) ,  Charuel J.-L. (Immunochemistry & Autoimmunity Laboratory, Department of Immunology, APHP, Pitie-Salpetriere University Hospital, Paris, France) ,  Musset L. (Immunochemistry & Autoimmunity Laboratory, Department of Immunology, APHP, Pitie-Salpetriere University Hospital, Paris, France) ,  Aussy A. (Department of Immunology, Rouen University Hospital, INSERM, Rouen Normandie University, Rouen, France) ,  Boyer O. (Department of Immunology, Rouen University Hospital, INSERM, Rouen Normandie University, Rouen, France) ,  Mariampillai K. (UMR974, Department of Internal Medicine and Clinical Immunology, Public Assistance-Hospitals of Paris (APHP), Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Mariampillai K. (Inflammation-Immunopathology-Biotherapy Department (DHU I2B), and Reference Center for Neuromuscular Pathologies, Institute of Myology, Paris, France) ,  Landon-Cardinal O. (UMR974, Department of Internal Medicine and Clinical Immunology, Public Assistance-Hospitals of Paris (APHP), Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Landon-Cardinal O. (Inflammation-Immunopathology-Biotherapy Department (DHU I2B), and Reference Center for Neuromuscular Pathologies, Institute of Myology, Paris, France) ,  Rasmussen C. (UMR974, Department of Internal Medicine and Clinical Immunology, Public Assistance-Hospitals of Paris (APHP), Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Rasmussen C. (Inflammation-Immunopathology-Biotherapy Department (DHU I2B), and Reference Center for Neuromuscular Pathologies, Institute of Myology, Paris, France) ,  Bolko L. (UMR974, Department of Internal Medicine and Clinical Immunology, Public Assistance-Hospitals of Paris (APHP), Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Bolko L. (Inflammation-Immunopathology-Biotherapy Department (DHU I2B), and Reference Center for Neuromuscular Pathologies, Institute of Myology, Paris, France) ,  Maisonobe T. (Reference Center for Neuromuscular Pathologies, Institute of Myology, APHP, Pitie-Salpetriere University Hospital, Paris, France) ,  Leonard-Louis S. (Reference Center for Neuromuscular Pathologies, Institute of Myology, APHP, Pitie-Salpetriere University Hospital, Paris, France) ,  Suzuki S. (Department of Neurology, Keio University School of Medicine, Tokyo, Japan) ,  Nishino I. (Department of Neuromuscular Research, National Institute of Neuroscience, Tokyo, Japan) ,  Nishino I. (Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan) ,  Stenzel W. (Department of Neuropathology, Charite-Universitaetsmedizin, Berlin, Germany) ,  Benveniste O. (UMR974, Department of Internal Medicine and Clinical Immunology, Public Assistance-Hospitals of Paris (APHP), Pitie-Salpetriere University Hospital, National Institute of Health and Medical Research (INSERM), Paris-Sorbonne University, Paris, France) ,  Benveniste O. (Inflammation-Immunopathology-Biotherapy Department (DHU I2B), and Reference Center for Neuromuscular Pathologies, Institute of Myology, Paris, France)
Material： Neuropathology and Applied Neurobiology  (Neuropathol Appl Neurobiol)
Volume： 45  Issue： 5  Page： 513-522  Publication year： 2019 
JST Material Number： A1520A  ISSN： 0305-1846  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： AIMS: To elucidate the diagnos...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1712452&from=J-GLOBAL&jstjournalNo=A1520A") }}

Thesaurus term： *Myositis ,  *Dermatomyositis ,  gene ,  human ,  Necrosis ,  *Mucus ,  autoantibody ,  *Proteins ,  sensitivity ,  *subset ,  synthase ,  *Diagnosis ,  dyeing ,  anti-MDA5 antibody
Semi thesaurus term： ミキソウイルス ,  特異性 , 【Automatic Indexing@JST】

Author keywords (6)： autoantibody ,  dermatomyositis ,  diagnostic marker ,  muscle pathology ,  myxovirus resistance protein A ,  type 1 interferon

JST classification (4)： Tumors(=neoplasms)of nervous system  (GN04000V) ,  Nervous system diseases  (GN03000O) ,  Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Basic neurology  (GN01020W)

Terms in the title (9)： 皮膚筋炎 ,  サブ ,  筋形質 ,  粘液 ,  ウイルス抵抗性 ,  蛋白質 ,  発現 ,  診断 ,  可能性